A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a major treatment gap.